Evaluating the Effectiveness of Memantine as Adjuvant Treatment on the Symptoms of Acute Mania in the Patients with Bipolar 1 Disorder

Vice Chancellor for Research of Arak University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Between 18 to 60 years old; Meet the criteria for bipolar disorder based on DSM-1V-TR diagnostic criteria and clinical interview by a psychiatrist; Existence of mania, with a minimum score of 20 in Young Mania Rating Scale; Lack of psychiatric diseases; Without mental retardation; Lack of any disease that make a problem in the clinical study; Do not consume narcotic, stimulants and alcohol except nicotine in the three last months; Do not electroconvulsive therapy in the previous month; Not pregnant; Without drug allergy and drug side effects history on the this study drugs; Do not consume memantine in the three last months; Lack of dementia, delirium, cognitive disorders and epilepsy. Exclusion criteria: Drugs side effect that causing discontinuation of consume them; Request by the patient or the patient's parent or legal guardian to withdraw from the study at any time of the study; Consume of alcohol or narcotic by the patient after starting the study; Lack of response to the drug therapy after 2 weeks.

发起方

Vice Chancellor for Research of Arak University of Medical Sciences